nondialysis-dependent
Showing 1 - 25 of 4,040
Standard-of-care Erythropoiesis-stimulating Agents on Forearm
Completed
- Cardiovascular Diseases
- Chronic Kidney Disease
- Darbepoetin Alfa
- +3 more
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Jan 7, 2020
Iron Deficiency Anemia Trial in Waltham (Ferumoxytol, Oral Iron)
Terminated
- Iron Deficiency Anemia
- Ferumoxytol
- Oral Iron
-
Waltham, MassachusettsAMAG Pharmaceuticals, Inc.
Mar 31, 2022
Iron Deficiency Anemia Trial in Waltham (Ferumoxytol)
Terminated
- Iron Deficiency Anemia
-
Waltham, MassachusettsAMAG Pharmaceuticals, Inc.
Mar 31, 2022
Exercise Training and Physical Rehabilitation in Chronic Kidney
Recruiting
- Renal Insufficiency, Chronic
- +2 more
-
Halmstad, Sweden
- +1 more
Oct 31, 2021
Chronic Kidney Disease Trial in Multiple Locations (TS-143)
Completed
- Chronic Kidney Disease
-
Multiple Locations, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022
Anemia in Chronic Kidney Disease in Non-dialysis Patients Trial in Worldwide (Roxadustat, Darbepoetin alfa)
Completed
- Anemia in Chronic Kidney Disease in Non-dialysis Patients
- Roxadustat
- Darbepoetin alfa
-
Vienna, Austria
- +124 more
Apr 19, 2021
Hemodialysis Access Failure Trial in Shanghai (pcsk9 inhibitor)
Recruiting
- Hemodialysis Access Failure
- pcsk9 inhibitor
-
Shanghai, Pudong, ChinaYuanyuan Xie
Sep 10, 2023
Anemia Trial in Valley Forge (Venofer, Ferrous Sulfate)
Completed
- Anemia
- Venofer
- Ferrous Sulfate
-
Valley Forge, PennsylvaniaLuitpold Pharmaceuticals
Sep 16, 2020
Anemia; Non-dialysis Dependent Chronic Kidney Disease Trial in Japan (MT-6548, Darbepoetin alfa)
Completed
- Anemia; Non-dialysis Dependent Chronic Kidney Disease
- MT-6548
- Darbepoetin alfa
-
Aichi, Japan
- +30 more
Aug 2, 2021
Exposure to Polluted Air Trial in Yangzhou
Active, not recruiting
- Exposure to Polluted Air
-
Yangzhou, Jiangsu, ChinaWenjing Zhao
Feb 21, 2023
PM2.5 Exposure and Ferroptosis in Seizures Patients
Active, not recruiting
- Exposure to Polluted Air
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of JiangNan University, Department of Pediat
Mar 5, 2023
Insufficient Breast Milk Syndrome Trial in Gainesville (Breast Pump suction pattern)
Not yet recruiting
- Insufficient Breast Milk Syndrome
- Breast Pump suction pattern
-
Gainesville, FloridaNeonatal intensive care unit at Shands children's hospital at th
Sep 25, 2023
Abuse Potential Trial in Overland Park (Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg)
Completed
- Abuse Potential
- Placebo
- +4 more
-
Overland Park, KansasAltasciences Clinical Kansas
Oct 19, 2023
Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)
Not yet recruiting
- Thalassemia, Beta
- Thalassemia Major
- VGB-Ex01
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Sep 11, 2023
Nephrotic Syndrome in Children, Telitacicept Trial in Hangzhou (Telitacicept)
Recruiting
- Nephrotic Syndrome in Children
- Telitacicept
-
Hangzhou, Zhejiang, ChinaChildren's Hospital, Zhejiang University School of Medicine
Nov 8, 2023
OSA Trial in Boston (Dynamic CO2, Sham CO2)
Not yet recruiting
- OSA
- Dynamic CO2
- Sham CO2
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 16, 2023
Stroke Trial (Educational intervention based on the Precede-Proceed Model for individuals caring for stroke home care patients)
Not yet recruiting
- Stroke
- Educational intervention based on the Precede-Proceed Model for individuals caring for stroke home care patients
- (no location specified)
Jun 14, 2023
Vineland II Scale of Long-term Development of Pyridoxine
Not yet recruiting
- Pyridoxine-Dependent Epilepsy
- VINELAND II
-
Angers, FranceCHU Angers
Sep 19, 2023
Effects of Lead Exposure on Ferroptosis Pathway
Recruiting
- Lead Poisoning
- Neurotoxicity
- Lead exposure
-
Yangzhou, Jiangsu, ChinaWenjing Zhao
Jul 19, 2023
MDS, Anemia Trial in Germany (Luspatercept Injection)
Recruiting
- Myelodysplastic Syndromes
- Anemia
- Luspatercept Injection
-
Berlin, Germany
- +18 more
Jan 25, 2023
OSA Trial in Boston (Acetazolamide, Placebo)
Not yet recruiting
- OSA
- Acetazolamide
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 16, 2023
Intermittent Fasting, Aging Trial in Oklahoma City (Time restricted eating)
Not yet recruiting
- Intermittent Fasting
- Aging
- Time restricted eating
-
Oklahoma City, OklahomaTranslational GeroScience Laboratory
Sep 5, 2023